Atropine and glycopyrrolate do not support bacterial growth—safety and economic considerations

• Published in: Journal of clinical anesthesia Vol. 35; pp. 560 - 563
• Main Authors: Ittzes, Balazs, Weiling, Zsolt, Batai, Istvan Zoard, Kerenyi, Monika, Batai, Istvan
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01.12.2016; Elsevier Limited
• Subjects: Acinetobacter; Acinetobacter baumannii; Acinetobacter baumannii - drug effects; Acinetobacter baumannii - growth & development; Adjuvants, Anesthesia - pharmacology; Alcohol; Anesthesia & Perioperative Care; Atropine; Atropine - pharmacology; Bacteria; Bacterial Load - drug effects; Bactericidal; Drugs; E coli; Equipment Contamination - prevention & control; Escherichia coli; Escherichia coli - drug effects; Escherichia coli - growth & development; Glycopyrrolate; Glycopyrrolate - pharmacology; Hospital finance; Laboratories; Medical wastes; Pain Medicine; Pseudomonas aeruginosa; Pseudomonas aeruginosa - drug effects; Pseudomonas aeruginosa - growth & development; Staphylococcus aureus; Staphylococcus aureus - drug effects; Staphylococcus aureus - growth & development; Staphylococcus infections; Streptococcus infections; United Kingdom > UK; Germany; Atropine; Glycopyrrolate; Hospital finance; Bactericidal

Evaluation of bacterial growth in atropine and glycopyrrolate. Laboratory investigation. Standard microbiological methods were used to evaluate the impact of atropine and glycopyrrolate on the growth of Acinetobacter baumannii, Pseudomonas aeruginosa, Staphylococcus aureus, and Escherichia coli. Bac...